Cas:661463-13-4 1-Bromo-5-fluoro-4-methoxy-2-nitrobenzene manufacturer & supplier

Chemical Name:1-Bromo-5-fluoro-4-methoxy-2-nitrobenzene

CAS.NO:661463-13-4

Synonyms:W7717;4-bromo-2-fluoro-5-nitrophenyl methyl ether

Molecular Formula:C₇H₅BrFNO₃

Molecular Weight:250.02200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:55.05000

Exact Mass:248.94400

LogP:3.02820

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like W7717 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-bromo-2-fluoro-5-nitrophenyl methyl ether physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,W7717 Use and application,W7717 technical grade,usp/ep/jp grade.

Related News: In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials. 1-Bromo-5-fluoro-4-methoxy-2-nitrobenzene manufacturer Alira is betting big on biometrics services by picking up Italy-based CROS NT, which has offices in Italy, London and North Carolina. The deal, for undisclosed terms, gives a boost to Alira’s direct clinical operations in Europe and access to biometrics services from the 29-year-old contract research organization. 1-Bromo-5-fluoro-4-methoxy-2-nitrobenzene supplier Alira is betting big on biometrics services by picking up Italy-based CROS NT, which has offices in Italy, London and North Carolina. The deal, for undisclosed terms, gives a boost to Alira’s direct clinical operations in Europe and access to biometrics services from the 29-year-old contract research organization. 1-Bromo-5-fluoro-4-methoxy-2-nitrobenzene vendor In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 1-Bromo-5-fluoro-4-methoxy-2-nitrobenzene factory Alira is betting big on biometrics services by picking up Italy-based CROS NT, which has offices in Italy, London and North Carolina. The deal, for undisclosed terms, gives a boost to Alira’s direct clinical operations in Europe and access to biometrics services from the 29-year-old contract research organization.